Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Spindle Cell Sarcoma Treatment Market, by Treatment Type
6.1 Introduction
6.2 Surgical Removal
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.1 Conservative Surgical Removal Type
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2 Wide Surgical Removal Type
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3 Cryotherapy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.4 Radiotherapy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5 Hormone Therapy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.6 Chemotherapy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 7. Global Spindle Cell Sarcoma Treatment Market, by End-User
7.1 Introduction
7.2 Laboratories
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3 Hospitals
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.4 Clinics
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.5 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 8. Global Spindle Cell Sarcoma Treatment Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 PharmaEngine, Inc
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Morphotek Inc
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Threshold Pharmaceutical
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Merck KGaA
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 NantCell Inc
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 NanoCarrier Co., Ltd
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Athenex, Inc
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s Viewpoint
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Predictions for the Dental 3D Printing Industry
Chapter 12. Appendix
LIST OF TABLES
Table 1 Global Spindle Cell Sarcoma Treatment Market Synopsis, 2020–2027
Table 2 Global Spindle Cell Sarcoma Treatment Market Estimates and Forecast, 2020–2027
(USD Million)
Table 3 Global Spindle Cell Sarcoma Treatment Market, by Region, 2020–2027 (USD Million)
Table 4 Global Spindle Cell Sarcoma Treatment Market, by Treatment Type, 2020–2027 (USD Million)
Table 5 Global Spindle Cell Sarcoma Treatment Market, by End-User, 2020–2027 (USD Million)
Table 6 North America: Electron Microscopy Market, by Treatment Type, 2020–2027 (USD Million)
Table 7 North America: Spindle Cell Sarcoma Treatment by End-User, 2020–2027 (USD Million)
Table 8 US: Global Spindle Cell Sarcoma Treatment Market, by Treatment Type, 2020–2027 (USD Million)
Table 9 US: Spindle Cell Sarcoma Treatment Market, by End-User, 2020–2027 (USD Million)
Table 10 Canada: Spindle Cell Sarcoma Treatment Market, by Treatment Type, 2020–2027 (USD Million)
Table 11 Canada: Global Spindle Cell Sarcoma Treatment Market, by End-User, 2020–2027 (USD Million)
Table 12 South America: Global Spindle Cell Sarcoma Treatment Market, by Treatment Type, 2020–2027 (USD Million)
Table 13 South America: Global Spindle Cell Sarcoma Treatment Market, by End-User, 2020–2027 (USD Million)
Table 14 Europe: Global Spindle Cell Sarcoma Treatment Market, by Treatment Type, 2020–2027 (USD Million)
Table 15 Europe: Global Spindle Cell Sarcoma Treatment Market, by End-User, 2020–2027 (USD Million)
Table 16 Western Europe: Global Spindle Cell Sarcoma Treatment Market, by Treatment Type, 2020–2027 (USD Million)
Table 17 Western Europe: Global Spindle Cell Sarcoma Treatment Market, by End-User, 2020–2027 (USD Million)
Table 18 Eastern Europe: Global Spindle Cell Sarcoma Treatment Market, by Treatment Type, 2020–2027 (USD Million)
Table 19 Eastern Europe: Spindle Cell Sarcoma Treatment Market, by End-User, 2020–2027 (USD Million)
Table 20 Asia-Pacific: Global Spindle Cell Sarcoma Treatment Market, by Treatment Type, 2020–2027 (USD Million)
Table 21 Asia-Pacific: Global Spindle Cell Sarcoma Treatment Market, by End-User, 2020–2027 (USD Million)
Table 22 Middle East & Africa: Global Spindle Cell Sarcoma Treatment Market, by Treatment Type, 2020–2027 (USD Million)
Table 23 Middle East & Africa: Spindle Cell Sarcoma Treatment Market, by End-User, 2020–2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Spindle Cell Sarcoma Treatment Market
Figure 3 Segmentation Market Dynamics for Global Spindle Cell Sarcoma Treatment Market
Figure 4 Global Spindle Cell Sarcoma Treatment Market Share, by Treatment Type, 2020
Figure 5 Global Spindle Cell Sarcoma Treatment Market Share, by End-User, 2020
Figure 6 Global Spindle Cell Sarcoma Treatment Market Share, by Region, 2020
Figure 7 North America: Global Spindle Cell Sarcoma Treatment Share, by Country, 2020
Figure 8 Europe: Global Spindle Cell Sarcoma Treatment Share, by Country, 2020
Figure 9 Asia-Pacific: Global Spindle Cell Sarcoma Treatment Share, by Country, 2020
Figure 10 Middle East & Africa: Global Spindle Cell Sarcoma Treatment Share, by Country, 2020
Figure 11 Global Spindle Cell Sarcoma Treatment Share: Company Share Analysis, 2020 (%)
Figure 12 PharmaEngine, Inc: Key Financials
Figure 13 PharmaEngine, Inc: Segmental Revenue
Figure 14 PharmaEngine, Inc: Geographical Revenue
Figure 15 Morphotek Inc.: Key Financials
Figure 16 Morphotek Inc.: Segmental Revenue
Figure 17 Morphotek Inc.: Geographical Revenue
Figure 18 Threshold Pharmaceutical.: Key Financials
Figure 19 Threshold Pharmaceutical.: Segmental Revenue
Figure 20 Threshold Pharmaceutical.: Geographical Revenue
Figure 21 Merck KGaA: Key Financials
Figure 22 Merck KGaA: Segmental Revenue
Figure 23 Merck KGaA: Geographical Revenue
Figure 24 NantCell Inc: Key Financials
Figure 25 NantCell Inc: Segmental Revenue
Figure 26 NantCell Inc. Geographical Revenue
Figure 27 NanoCarrier Co., Ltd: Key Financials
Figure 28 NanoCarrier Co., Ltd: Segmental Revenue
Figure 29 NanoCarrier Co., Ltd: Geographical Revenue
Figure 30 Athenex, Inc: Key Financials
Figure 31 Athenex, Inc: Segmental Revenue
Figure 32 Athenex, Inc: Geographical Revenue
Spindle Cell Sarcoma Treatment Market
Spindle cell sarcoma treatment market is expected to grow at USD 1,405 million by 2027, at a CAGR 12.4% during the forecast period
$1,405 million
Market Size
12.4%
CAGR
North America
Dominating Region
2020-2027
Forecast Period
Segmentation
Key Players
- PharmaEngine
- Morphotek Inc
- Threshold Pharmaceutical
- Merck KGaA
- NantCell Inc
- NanoCarrier Co.
- Athenex
Drivers
- production of new medicines
- alternative treatment
- conduction of awareness program by government
Spindle Cell Sarcoma Treatment Market Overview
Spindle cell sarcoma treatment market is expected to register a CAGR ~6.1% during the forecast period Spindle cell sarcoma is an uncommon malignant tumor that can be established in bone or soft tissue. It can also arise in other body parts most typically in limbs (arms and legs). This form of tumor has no known etiology, but it can sometimes develop as a result of earlier radiotherapy treatment. Fever, weakness, anxiety, and confusion are all signs and symptoms of spindle cell sarcoma. Treatment with chemotherapy is the best strategy to cure and prevent the spindle cell sarcoma. Other variables, such as the development of new medicines, alternative treatments, and government-led public awareness campaigns, encourage the market to develop new therapies to treat spindle cell sarcoma.
Spindle cell sarcomas are treated with a variety of chemotherapeutic medicines, including dacarbazine, epirubicin, and others. In the projected term, the presence of a robust developmental pipeline is expected to accelerate market expansion. Similarly, the market for spindle cell sarcoma medications is expected to develop due to the increased adoption of innovative therapies and an increase in the prevalence of soft tissue sarcomas (STS). Furthermore, the market growth rate is expected to be fueled by significant technical advancements in treatment and diagnosis, as well as an increase in the incidence of sarcoma. Additionally, the government's increased awareness campaign to encourage the market to develop new treatments to treat spindle cell sarcoma is projected to have an impact on the global spindle cell sarcoma drugs market.
Segmentation
The spindle cell sarcoma treatment market has been segmented on the basis of types of treatment and end-user.
On the basis of types of treatment, the spindle cell sarcoma treatment market is segmented into surgical removal, cryotherapy, radiotherapy, hormone therapy, and chemotherapy. Surgical therapy is further sub-segmented into conservative surgical removal type and wide surgical removal type.
On the basis of end-user, the spindle cell sarcoma treatment market is segmented into hospital, clinics, and others.
Key players
Key players for the spindle cell sarcoma treatment market are PharmaEngine, Inc, Morphotek Inc, Threshold Pharmaceutical, Merck KGaA, NantCell Inc, NanoCarrier Co., Ltd, Athenex, Inc.
Regional Market Summary
Spindle Cell Sarcoma Treatment Market Share (%), by Region, 2017
Source: Centers for Disease Control and Prevention (CDC)
On a regional basis, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Americas is likely to dominate the spindle cell sarcoma treatment market owing to the remarkable use of chemotherapy for the prevention of disease and favorable conditions for research and development.
According to a scientific report, of Surveillance, Epidemiology and End Results (SEER) database white people account for 79.1 % with spindle cell sarcoma cancer within the median age of 57 years.
Europe is the second largest market for the spindle cell sarcoma treatment followed by Asia-Pacific. Due to the availability of fund for research and development activity and growing emphasis on treating disease. Asia-Pacific shows the fastest growth in the market due to an increase in the prevalence of communicable disease. India and China are expected to be the fastest growing market for spindle cell sarcoma treatment.
The Middle East and Africa has the lowest market for spindle cell sarcoma treatment due to poor medical facilities and lack of technology.
Spindle Cell Sarcoma Treatment Market, by Types of Treatment
- Radiotherapy
- Chemotherapy
- Hormone Therapy
- Surgical Removal
- Conservative Surgical Removal Type
- Wide Surgical Removal Type
- Cryotherapy
Spindle Cell Sarcoma Treatment Market, by End-User
- Laboratories
- Hospitals
- Clinics
- Others
Spindle Cell Sarcoma Treatment Market, by Region
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Republic of Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Spindle Cell Sarcoma Treatment Market, by Key Players
- PharmaEngine, Inc
- Morphotek Inc
- Threshold Pharmaceutical
- Merck KGaA
- NantCell Inc
- NanoCarrier Co., Ltd
- Athenex, Inc.
Recent Developmet
PharmaEngine, Inc. is a company in the market for sarcoma medications that are highly consolidated. In terms of market share, all of the companies are currently dominant including this.
Mid-size to smaller enterprises are projected to infiltrate the market by introducing new pharmaceuticals at lower prices, thanks to technology developments and product innovations. As a result, these newcomers are expected to have a significant future share including Morphotek Inc.
Intended Audience
- Hospitals and clinics
- Laboratories and associations
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 6.1% (2018-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Types of treatment and End-user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | PharmaEngine, Inc, Morphotek Inc, Threshold Pharmaceutical, Merck KGaA, NantCell Inc, NanoCarrier Co., Ltd, Athenex, Inc. |
| Key Market Opportunities | key players in the market are engaged in new launches of chemotherapy drugs and strategic collaborations |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Spindle cell sarcoma treatment market CAGR would be 6.1% during the forecast period.
Spindle cell sarcoma treatment market hurdles would be failure to follow distraction protocols and its adverse impact on the nerves.
Spindle cell sarcoma treatment market has segments like hormone therapy, cryotherapy, surgical removal, radiotherapy, and chemotherapy.
The end users are hospitals, clinics, and others.
The Americas would ensure maximum growth for the spindle cell sarcoma treatment market.
